Sfoglia per Autore
Erratum
2013-01-01 Licchetta, L.; Pippucci, T.; Bisulli, F.; Cantalupo, G.; Magini, P.; Alvisi, L.; Baldassari, S.; Martinelli, P.; Naldi, I.; Vanni, N.; Liguori, R.; Seri, M.; Tinuper, P.
New insights into potential risk factors and associations in genital lichen sclerosus: Data from a multicentre Italian study on 729 consecutive cases
2017-01-01 Virgili, A; Borghi, A; Cazzaniga, S; Di Landro, A; Naldi, Luigi; Minghetti, S; Verrone, A; Stroppiana, E; Caproni, M; Nasca, M R; D'Antuono, A; Papini, M; Di Lernia, V; Corazza, Marco; Schena, D; Girolomoni, G
Cutaneous manifestations of SARS-CoV-2 infection: a clinical update
2020-01-01 Gisondi, P; Piaserico, S.; Bordin, C.; Alaibac, M.; Girolomoni, G.; Naldi, L.
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis
2020-01-01 Gisondi, Paolo; Geat, Davide; Conti, Andrea; Dapavo, Paolo; Piaserico, Stefano; De Simone, Clara; Bianchi, Luca; Costanzo, Antonio; Malagoli, Piergiorgio; Malara, Giovanna; Micali, Giuseppe; Naldi, Luigi; Offidani, Annamaria; Patrizi, Annalisa; Prignano, F.; Parodi, Aurora; Rongioletti, Franco; Calzavara-Pinton, Piergiacomo; Girolomoni, Giampiero
Gender differences in genital lichen sclerosus: data from a multicenter Italian study on 729 consecutive cases
2020-01-01 Virgili, Annarosa; Borghi, Alessandro; Cazzaniga, Simone; DI LANDRO, Anna; Naldi, Luigi; Minghetti, Sara; Fierro, Maria T.; Verrone, Anna; Caproni, Marzia; Micali, Giuseppe; Gaspari, Valeria; Papini, Manuela; DI LERNIA, Vito; Germi, Lerica; Girolomoni, Giampiero; BELLONI FORTINA, Anna; Cannavò, Serafinella P.; Bilenchi, Roberta; Corazza, Monica; ‡, on behalf of the GLS Italian Study Group
Incidence rates of hospitalization and death from {COVID}-19 in patients with psoriasis receiving biological treatment: A~Northern Italy experience
2020-01-01 Gisondi, Paolo; Piaserico, Stefano; Naldi, Luigi; Dapavo, Paolo; Conti, Andrea; Malagoli, Piergiorgio; Valerio Marzano, Angelo; Bardazzi, Federico; Gasperini, Massimo; Cazzaniga, Simone; Costanzo, Antonio; Sacchelli, Lidia; Pezzolo, Elena; Messina, Francesco; Lasagni, Claudia; Bigi, Laura; Cattaneo, Angelo; Giovanni Carrera, Carlo; Arancio, Luisa; Ribero, Simone; Rozzo, Giulia; Damiani, Giovanni; Facheris, Paola
Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis
2020-01-01 Tessari, G; Maggiore, U; Zaza, G; Momo, Ren; Nacchia, F; Boschiero, L; Sandrini, S; Naldi, L; Gotti, E; Campise, M; Messa, P; Palmisano, A; Capelli, I; Minetti, E; Rossini, M; Girolomoni, G
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs
2021-01-01 Gisondi, Paolo; Bellinato, Francesco; Piaserico, Stefano; Di Leo, Sara; Cazzaniga, Simone; Naldi, Luigi
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
2021-01-01 Gisondi, Paolo; Piaserico, Stefano; Naldi, Luigi; Dapavo, Paolo; Conti, Andrea; Malagoli, Piergiorgio; Valerio Marzano, Angelo; Bardazzi, Federico; Gasperini, Massimo; Cazzaniga, Simone; Costanzo, Antonio
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review
2021-01-01 Gisondi, Paolo; Di Leo, Sara; Bellinato, Francesco; Cazzaniga, Simone; Piaserico, Stefano; Naldi, Luigi
Impact of the COVID-19 pandemic on melanoma diagnosis
2021-01-01 Gisondi, Paolo; Cazzaniga, Simone; Di Leo, Sara; Piaserico, Stefano; Bellinato, Francesco; Pizzolato, Miriam; Gatti, Alessandro; Eccher, Albino; Brunelli, Matteo; Saraggi, Deborah; Girolomoni, Giampiero; Naldi, Luigi
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events
2021-01-01 Gisondi, Paolo; Piaserico, Stefano; Bordin, Chiara; Bellinato, Francesco; Tozzi, Francesca; Alaibac, Mauro; Girolomoni, Giampiero; Naldi, Luigi
Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensus
2022-01-01 Costanzo, Antonio; Bardazzi, Federico; DE SIMONE, Clara; Fabbrocini, Gabriella; Foti, Caterina; Marzano, Angelo V.; Naldi, Luigi; Parodi, Aurora; Prignano, Francesca; Girolomoni, Giampiero
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence
2022-01-01 Piaserico, Stefano; Gisondi, Paolo; Cazzaniga, Simone; Di Leo, Sara; Naldi, Luigi
European consensus statement on phenotypes of pustular psoriasis
2024-01-01 Navarini, Aa; Burden, Ad; Capon, F; Mrowietz, U; Puig, L; Koks, S; Kingo, K; Smith, C; Barker, Jn; Bachelez, H; Chiricozzi, A; Costanzo, A; Eyerich, K; French, Le; Ghoreschi, K; Gilliet, M; Girolomoni, G; Gniadecki, R; Griffiths, C; Koh, Hy; Lipsker, D; Naldi, L; Prans, E; Prinz, J; Reich, K; Rocken, M; Skov, L; Sorin, G; Stahle, M; Stingl, G; Van De Kerkhof, P; Warren, R
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study
2024-01-01 Pezzolo, Elena; Schena, Donatella; Gambardella, Alessio; Rossi, Mariateresa; Barei, Francesca; Calzavara Pinton, Piergiacomo; Girolomoni, Giampiero; Naldi, Luigi; Ferrucci, Silvia Mariel
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Erratum | 1-gen-2013 | Licchetta, L.; Pippucci, T.; Bisulli, F.; Cantalupo, G.; Magini, P.; Alvisi, L.; Baldassari, S.; Martinelli, P.; Naldi, I.; Vanni, N.; Liguori, R.; Seri, M.; Tinuper, P. | |
| New insights into potential risk factors and associations in genital lichen sclerosus: Data from a multicentre Italian study on 729 consecutive cases | 1-gen-2017 | Virgili, A; Borghi, A; Cazzaniga, S; Di Landro, A; Naldi, Luigi; Minghetti, S; Verrone, A; Stroppiana, E; Caproni, M; Nasca, M R; D'Antuono, A; Papini, M; Di Lernia, V; Corazza, Marco; Schena, D; Girolomoni, G | |
| Cutaneous manifestations of SARS-CoV-2 infection: a clinical update | 1-gen-2020 | Gisondi, P; Piaserico, S.; Bordin, C.; Alaibac, M.; Girolomoni, G.; Naldi, L. | |
| TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis | 1-gen-2020 | Gisondi, Paolo; Geat, Davide; Conti, Andrea; Dapavo, Paolo; Piaserico, Stefano; De Simone, Clara; Bianchi, Luca; Costanzo, Antonio; Malagoli, Piergiorgio; Malara, Giovanna; Micali, Giuseppe; Naldi, Luigi; Offidani, Annamaria; Patrizi, Annalisa; Prignano, F.; Parodi, Aurora; Rongioletti, Franco; Calzavara-Pinton, Piergiacomo; Girolomoni, Giampiero | |
| Gender differences in genital lichen sclerosus: data from a multicenter Italian study on 729 consecutive cases | 1-gen-2020 | Virgili, Annarosa; Borghi, Alessandro; Cazzaniga, Simone; DI LANDRO, Anna; Naldi, Luigi; Minghetti, Sara; Fierro, Maria T.; Verrone, Anna; Caproni, Marzia; Micali, Giuseppe; Gaspari, Valeria; Papini, Manuela; DI LERNIA, Vito; Germi, Lerica; Girolomoni, Giampiero; BELLONI FORTINA, Anna; Cannavò, Serafinella P.; Bilenchi, Roberta; Corazza, Monica; ‡, on behalf of the GLS Italian Study Group | |
| Incidence rates of hospitalization and death from {COVID}-19 in patients with psoriasis receiving biological treatment: A~Northern Italy experience | 1-gen-2020 | Gisondi, Paolo; Piaserico, Stefano; Naldi, Luigi; Dapavo, Paolo; Conti, Andrea; Malagoli, Piergiorgio; Valerio Marzano, Angelo; Bardazzi, Federico; Gasperini, Massimo; Cazzaniga, Simone; Costanzo, Antonio; Sacchelli, Lidia; Pezzolo, Elena; Messina, Francesco; Lasagni, Claudia; Bigi, Laura; Cattaneo, Angelo; Giovanni Carrera, Carlo; Arancio, Luisa; Ribero, Simone; Rozzo, Giulia; Damiani, Giovanni; Facheris, Paola | |
| Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis | 1-gen-2020 | Tessari, G; Maggiore, U; Zaza, G; Momo, Ren; Nacchia, F; Boschiero, L; Sandrini, S; Naldi, L; Gotti, E; Campise, M; Messa, P; Palmisano, A; Capelli, I; Minetti, E; Rossini, M; Girolomoni, G | |
| Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs | 1-gen-2021 | Gisondi, Paolo; Bellinato, Francesco; Piaserico, Stefano; Di Leo, Sara; Cazzaniga, Simone; Naldi, Luigi | |
| Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience | 1-gen-2021 | Gisondi, Paolo; Piaserico, Stefano; Naldi, Luigi; Dapavo, Paolo; Conti, Andrea; Malagoli, Piergiorgio; Valerio Marzano, Angelo; Bardazzi, Federico; Gasperini, Massimo; Cazzaniga, Simone; Costanzo, Antonio | |
| Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review | 1-gen-2021 | Gisondi, Paolo; Di Leo, Sara; Bellinato, Francesco; Cazzaniga, Simone; Piaserico, Stefano; Naldi, Luigi | |
| Impact of the COVID-19 pandemic on melanoma diagnosis | 1-gen-2021 | Gisondi, Paolo; Cazzaniga, Simone; Di Leo, Sara; Piaserico, Stefano; Bellinato, Francesco; Pizzolato, Miriam; Gatti, Alessandro; Eccher, Albino; Brunelli, Matteo; Saraggi, Deborah; Girolomoni, Giampiero; Naldi, Luigi | |
| The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events | 1-gen-2021 | Gisondi, Paolo; Piaserico, Stefano; Bordin, Chiara; Bellinato, Francesco; Tozzi, Francesca; Alaibac, Mauro; Girolomoni, Giampiero; Naldi, Luigi | |
| Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensus | 1-gen-2022 | Costanzo, Antonio; Bardazzi, Federico; DE SIMONE, Clara; Fabbrocini, Gabriella; Foti, Caterina; Marzano, Angelo V.; Naldi, Luigi; Parodi, Aurora; Prignano, Francesca; Girolomoni, Giampiero | |
| Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence | 1-gen-2022 | Piaserico, Stefano; Gisondi, Paolo; Cazzaniga, Simone; Di Leo, Sara; Naldi, Luigi | |
| European consensus statement on phenotypes of pustular psoriasis | 1-gen-2024 | Navarini, Aa; Burden, Ad; Capon, F; Mrowietz, U; Puig, L; Koks, S; Kingo, K; Smith, C; Barker, Jn; Bachelez, H; Chiricozzi, A; Costanzo, A; Eyerich, K; French, Le; Ghoreschi, K; Gilliet, M; Girolomoni, G; Gniadecki, R; Griffiths, C; Koh, Hy; Lipsker, D; Naldi, L; Prans, E; Prinz, J; Reich, K; Rocken, M; Skov, L; Sorin, G; Stahle, M; Stingl, G; Van De Kerkhof, P; Warren, R | |
| Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study | 1-gen-2024 | Pezzolo, Elena; Schena, Donatella; Gambardella, Alessio; Rossi, Mariateresa; Barei, Francesca; Calzavara Pinton, Piergiacomo; Girolomoni, Giampiero; Naldi, Luigi; Ferrucci, Silvia Mariel |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile